In this video, AutoTopNL takes the incredible $500,000 Porsche 911 CSF RSR restomod for a thrilling test on the German ...

Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and ...

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

A technology that diagnoses various diseases, including Alzheimer’s and Parkinson’s, using just a few drops of blood from a ...

Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...

Long before memory problems appear, your brain may already be losing neurons. That is the unsettling message from new work by ...

A new breakthrough study from the Rotman Research Institute at Baycrest, University of Toronto (Motsenyat et al., Brain Stimulation 2025) shows that brief sessions of pulsed photobiomodulation (PBM) ...

Plasma measures of phosphorylated tau217 (p-tau217) can accurately identify individuals in the preclinical stage of Alzheimer’s disease (AD), a new meta-analysis showed. The results are important ...

Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.